1. Home
  2. NUWE vs LEO Comparison

NUWE vs LEO Comparison

Compare NUWE & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • LEO
  • Stock Information
  • Founded
  • NUWE 1999
  • LEO 1987
  • Country
  • NUWE United States
  • LEO United States
  • Employees
  • NUWE N/A
  • LEO N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LEO Trusts Except Educational Religious and Charitable
  • Sector
  • NUWE Health Care
  • LEO Finance
  • Exchange
  • NUWE Nasdaq
  • LEO Nasdaq
  • Market Cap
  • NUWE 3.9M
  • LEO N/A
  • IPO Year
  • NUWE N/A
  • LEO N/A
  • Fundamental
  • Price
  • NUWE $1.00
  • LEO $5.83
  • Analyst Decision
  • NUWE Strong Buy
  • LEO
  • Analyst Count
  • NUWE 1
  • LEO 0
  • Target Price
  • NUWE $17.00
  • LEO N/A
  • AVG Volume (30 Days)
  • NUWE 66.9K
  • LEO 200.2K
  • Earning Date
  • NUWE 05-06-2025
  • LEO 01-01-0001
  • Dividend Yield
  • NUWE N/A
  • LEO 4.01%
  • EPS Growth
  • NUWE N/A
  • LEO N/A
  • EPS
  • NUWE N/A
  • LEO 0.04
  • Revenue
  • NUWE $8,740,000.00
  • LEO N/A
  • Revenue This Year
  • NUWE $22.96
  • LEO N/A
  • Revenue Next Year
  • NUWE $29.97
  • LEO N/A
  • P/E Ratio
  • NUWE N/A
  • LEO $152.00
  • Revenue Growth
  • NUWE N/A
  • LEO N/A
  • 52 Week Low
  • NUWE $0.75
  • LEO $4.98
  • 52 Week High
  • NUWE $12.60
  • LEO $6.50
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 53.14
  • LEO 43.70
  • Support Level
  • NUWE $0.86
  • LEO $5.67
  • Resistance Level
  • NUWE $0.95
  • LEO $5.88
  • Average True Range (ATR)
  • NUWE 0.08
  • LEO 0.12
  • MACD
  • NUWE 0.02
  • LEO 0.01
  • Stochastic Oscillator
  • NUWE 92.59
  • LEO 50.00

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: